Long-term study of IGE025 in moderate to severe bronchial asthma.
Phase of Trial: Phase III
Latest Information Update: 13 Dec 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 24 Oct 2011 Actual initiation date (Nov 2003) added as reported by ClinicalTrials.gov.
- 24 Oct 2011 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 11 Jun 2007 Status changed from in progress to completed.